Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Follow-Up Questions
Who is the CEO of Masimo Corp?
Ms. Catherine Szyman is the Chief Executive Officer of Masimo Corp, joining the firm since 2025.
What is the price performance of MASI stock?
The current price of MASI is $148.15, it has increased 0.93% in the last trading day.
What are the primary business themes or industries for Masimo Corp?
Masimo Corp belongs to Health Care industry and the sector is Health Care
What is Masimo Corp market cap?
Masimo Corp's current market cap is $8.0B
Is Masimo Corp a buy, sell, or hold?
According to wall street analysts, 10 analysts have made analyst ratings for Masimo Corp, including 5 strong buy, 7 buy, 3 hold, 0 sell, and 5 strong sell
